Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact

Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology

(2013) Sarah N. Lauder et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine

(2013) S. Rockman et al.   JOURNAL OF VIROLOGY

H7N9 Influenza Viruses Are Transmissible in Ferrets by Respiratory Droplet

(2013) Q. Zhang et al.   SCIENCE

The severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic H1N1 influenza virus

(2013) Heui Man Kim et al.   VIROLOGY

Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets

(2013) Erhard van der Vries et al.   PLoS Pathogens

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir

(2012) Nigel J. Dimmock et al.   ANTIVIRAL RESEARCH

Experimental human influenza: observations from studies of influenza antivirals

(2012) Frederick G Hayden   ANTIVIRAL THERAPY

Pharmacokinetic Properties ofAnti-Influenza Neuraminidase Inhibitors

(2012) Kalayanee Chairat et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients

(2012) S. G. Muthuri et al.   JOURNAL OF INFECTIOUS DISEASES

Transmission of a 2009 H1N1 Pandemic Influenza Virus Occurs before Fever Is Detected, in the Ferret Model

(2012) Kim L. Roberts et al.   PLoS One

Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets

(2011) Elena A. Govorkova et al.   ANTIVIRAL RESEARCH

A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses

(2011) Yi-Mo Deng et al.   ANTIVIRAL RESEARCH

Very low pandemic influenza A (H1N1) 2009 mortality associated with early neuraminidase inhibitor treatment in Japan: Analysis of 1000 hospitalized children

(2011) Norio Sugaya et al.   JOURNAL OF INFECTION

Local Innate Immune Responses and Influenza Virus Transmission and Virulence in Ferrets

(2011) Taronna R. Maines et al.   JOURNAL OF INFECTIOUS DISEASES

Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model

(2010) Aeron C. Hurt et al.   ANTIVIRAL RESEARCH

Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response

(2010) Jodie McVernon et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH

Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009

(2010) Vernon J Lee et al.   BMC INFECTIOUS DISEASES

Household transmission of pandemic 2009 influenza A (H1N1) virus in Osaka, Japan in May 2009

(2010) N. Komiya et al.   JOURNAL OF INFECTION

Antiviral Treatment for Patients Hospitalized with 2009 Pandemic Influenza A (H1N1)

(2009) Tim Uyeki   NEW ENGLAND JOURNAL OF MEDICINE

MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells

(2008) D. Y. Oh et al.   JOURNAL OF CLINICAL MICROBIOLOGY